Thyroid storm is a medical emergency. Admit to an ICU or high-dependency unit for continuous cardiac monitoring, frequent temperature and neurologic assessment, and early endocrinology/critical-care input.
Immediate management
1. Stabilize and identify the trigger
- Airway, oxygen, IV access, cardiac monitoring.
- Careful IV fluids and electrolyte/glucose replacement. Assess for heart failure before aggressive fluids.
- Cooling measures plus paracetamol/acetaminophen for fever.
- Avoid aspirin/salicylates, which can increase free thyroid hormone by displacing it from protein binding.
- Benzodiazepine if severe agitation.
- Search for and treat precipitants: infection/sepsis, missed antithyroid drugs, surgery/trauma, myocardial infarction, pulmonary embolism, diabetic ketoacidosis, iodinated contrast, childbirth, etc. Obtain cultures and give empiric antibiotics if infection is suspected.
2. Block adrenergic effects
Use a beta-blocker unless there is shock, decompensated heart failure, severe asthma, or another contraindication.
- Propranolol: 40-80 mg orally every 4-6 hours, if oral treatment is feasible.
- In a closely monitored ICU setting, short-acting esmolol is often useful because it can be rapidly stopped if hypotension or low-output heart failure develops.
- If beta-blockade is contraindicated, diltiazem may control rate, though it requires caution in ventricular dysfunction.
Beta-blockade should be started cautiously if there is possible cardiogenic shock or severe thyrotoxic cardiomyopathy.
Endotext’s treatment review notes reported vascular collapse with overly aggressive beta-blockade in severe thyrotoxicosis.
3. Block new thyroid-hormone synthesis: give a thionamide
- PTU: 500-1000 mg loading dose, then 250 mg every 4 hours.
- Advantage: also reduces peripheral conversion of T4 to T3.
- Methimazole: 20 mg every 4-6 hours, or approximately 60-80 mg/day in divided doses.
- Often preferred after initial stabilization because of PTU hepatotoxicity risk.
If vomiting, ileus, or poor gut absorption is likely, use an appropriate non-oral route in consultation with endocrinology/pharmacy.
4. Block hormone release: iodine, only after thionamide
Give iodine at least 1 hour after PTU or methimazole. Giving iodine first can provide substrate for further hormone synthesis.
Options:
- SSKI: 5 drops orally every 6 hours, or
- Lugol iodine, depending on local protocol and formulation.
The sequence is:
beta-blocker → thionamide → wait at least 1 hour → iodine.
StatPearls’ management summary gives this sequence and commonly used doses.
5. Give glucocorticoid
This treats possible relative adrenal insufficiency and decreases T4-to-T3 conversion.
- Hydrocortisone: 100 mg IV every 8 hours, or
- Dexamethasone: 2 mg IV every 6 hours.
Adjuncts and refractory storm
- Cholestyramine can reduce enterohepatic recirculation of thyroid hormone, especially in severe or refractory cases.
- Treat acute heart failure, arrhythmias, ischemia, hepatic dysfunction, and other organ failure with ICU support.
- Therapeutic plasma exchange can be considered for life-threatening disease refractory to standard therapy, or where thionamides are contraindicated, while arranging definitive therapy.
- Urgent thyroidectomy is rarely needed but may be considered after stabilization when medical therapy fails or is not possible.
Important cause-specific caveat
If the thyrotoxicosis is due to
destructive thyroiditis rather than Graves disease or toxic nodular disease, thionamides do not work because hormone is being released from damaged thyroid tissue rather than newly synthesized. Manage supportively, control adrenergic symptoms, and treat the underlying cause with specialist input.
Endotext discusses this distinction.
After stabilization
- Stop iodine after the acute phase.
- Taper glucocorticoids.
- If PTU was used initially, generally switch to methimazole once stable unless a specific reason exists not to.
- Plan definitive treatment for the underlying hyperthyroidism, usually radioiodine or thyroidectomy when appropriate.
Recent evidence does not alter the core acute sequence above. A 2024 systematic review discusses plasma exchange and alternative approaches mainly when standard therapy is contraindicated or fails (PMID: 39722810).